Impact of ranolazine on ventricular arrhythmias – A systematic review

Ranolazine is a new medication for the treatment of refractory angina. However, except its anti‐anginal properties, it has been found to act as an anti‐arrhythmic. The aim of our systematic review is to present the existing data about the impact of ranolazine in ventricular arrhythmias. We searched...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazoukis, George, Tse, Gary, Letsas, Konstantinos P., Thomopoulos, Costas, Naka, Katerina K., Korantzopoulos, Panagiotis, Bazoukis, Xenophon, Michelongona, Paschalia, Papadatos, Stamatis S., Vlachos, Konstantinos, Liu, Tong, Efremidis, Michael, Baranchuk, Adrian, Stavrakis, Stavros, Tsioufis, Costas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891418/
https://www.ncbi.nlm.nih.gov/pubmed/29657587
http://dx.doi.org/10.1002/joa3.12031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891418/
https://www.ncbi.nlm.nih.gov/pubmed/29657587
http://dx.doi.org/10.1002/joa3.12031

Ejemplares similares